BioNTech SE: CEO Sahin Ugur sold 63,209 shares

What happened

• Sahin Ugur, CEO, sold a total of 63,209 ordinary shares of BioNTech SE. He sold 27,000 shares at $92.31 on Oct 8, 2026 for $2,492,483 and 36,209 shares at $95.37 on Oct 9, 2026 for $3,453,372, totaling $5,945,855.

Key details

• Transaction dates and prices: Oct 8, 2026 — 27,000 shares at $92.31; Oct 9, 2026 — 36,209 shares at $95.37.
• Transaction type: Open market or private sale (S) as reported on the Form 4.
• Shares owned after the transactions: not stated on the filing.
• Footnote: The ordinary shares are held by Medine GmbH; the reporting person is the sole shareholder of Medine GmbH. 106,721 shares noted are held for the benefit of an individual under a trust, where Medine GmbH exercises voting power but not dispositive power. The reporting person may be deemed to beneficially own the shares held by Medine GmbH.
• Trading plan: The sales were effected pursuant to a Rule 10b5-1 trading plan established Jun 3, 2026.
• Filing date and timeliness: Form filed on Oct 9, 2026; the filing does not indicate it was late.

Why it may matter

• The filing reports market/private sales executed under a Rule 10b5-1 plan; the filing lists sales (code S), not option exercises or gifts.
• A filing does not show why the insider traded or why the company acted.